eed for steroid use after routine cataract surgery
- Conditions
- Health Condition 1: null- Those undergoing cataract surgery by standard phacoemulsification and hydrophobic foldable intraocular lens implantation
- Registration Number
- CTRI/2016/04/006806
- Lead Sponsor
- The Calcutta Medical Research Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 240
1.Uncomplicated cases of Phacoemulsification with IOL implantation. Uncomplicated being defined as
a.No capsular dehiscence
b.Placement of single piece foldable IOL in the capsular bag
c.No sutures applied
2.Includes surgeries where there have been iris handling/trauma (e.g. due to IFIS) or where iris retractors were used
3.Includes surgeries done under GA/Peri-bulbar block/Topical anaesthesia
4.Includes per-operative use of intra-cameral adrenaline and/or trypan blue
1.Presence of intra-ocular inflammation.
2.History of uveitis â?? anterior/posterior/pan.
3.Rubeosis iridis.
4.Diabetic eye disease including any diabetic retinopathy (even background).
5.History of herpes simplex/HZO (as there may be corneal anaesthesia and subsequent epithelial problems with NSAID therapy).
6.Glaucoma patients on prostaglandin analogue medication.
7.Ocular surface damage secondary to dry eye disease involving staining of the cornea. Conjunctival staining alone is not an exclusion criteria.
8.Use of per-operative intra-cameral antibiotics and/or lignocaine
9.Any intraocular procedure in the last 3 months.
10.Lost to follow up.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anterior segment inflammation <br/ ><br>PainTimepoint: 1,3 and 5 weeks post surgery
- Secondary Outcome Measures
Name Time Method Cystiod macular oedemaTimepoint: 1,3 and 5 weeks post surgery